Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Batroxobin Injection

Approval Number

国药准字H20030295

Company北京托毕西药业有限公司

Registration Date

September 4, 2020

Previous Approval Numbers

国药准字H20030295

Drug Information

Generic Name

巴曲酶注射液

Trade Name

东菱迪芙

Brand Name

东秦

Dosage Form

注射剂(小容量注射剂)

Strength

0.5ml:5BU

Drug Type

化学药品

Registration Date

September 4, 2020

Company Information

Applicant Company

Company Name北京托毕西药业有限公司

Company Address

北京市海淀区吴家村路11号

Manufacturing Company

Company Name北京托毕西药业有限公司

Company Address

北京市海淀区吴家村路11号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy